<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:33:59Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2668911" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2668911</identifier><datestamp>2009-04-14</datestamp><setSpec>bmjgroup</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://dtd.nlm.nih.gov/ns/archiving/2.3/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://dtd.nlm.nih.gov/ns/archiving/2.3/ https://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article" xml:lang="EN">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Br J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">bjo</journal-id>
      <journal-title>The British Journal of Ophthalmology</journal-title>
      <issn pub-type="ppub">0007-1161</issn>
      <issn pub-type="epub">1468-2079</issn>
      <publisher>
        <publisher-name>BMJ Publishing Group</publisher-name>
        <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2668911</article-id>
      <article-id pub-id-type="pmcid">PMC2668911</article-id>
      <article-id pub-id-type="pmc-uid">2668911</article-id>
      <article-id pub-id-type="pmid">19028736</article-id>
      <article-id pub-id-type="publisher-id">bj145193</article-id>
      <article-id pub-id-type="doi">10.1136/bjo.2008.145193</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Science</subject>
          <subj-group subj-group-type="Article Type">
            <subject>Original Articles</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>1506</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Molecular analysis of the <italic>ABCA4</italic> gene for reliable detection of allelic variations in Spanish patients: identification of 21 novel variants</article-title>
        <alt-title alt-title-type="running-head">Clinical science</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aguirre-Lamban</surname>
            <given-names>J</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Riveiro-Alvarez</surname>
            <given-names>R</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maia-Lopes</surname>
            <given-names>S</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cantalapiedra</surname>
            <given-names>D</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vallespin</surname>
            <given-names>E</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Avila-Fernandez</surname>
            <given-names>A</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Villaverde-Montero</surname>
            <given-names>C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trujillo-Tiebas</surname>
            <given-names>M J</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ayuso</surname>
            <given-names>C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Genetics Department, Fundacion Jimenez Diaz, Madrid, Spain</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal</addr-line>
      </aff>
      <author-notes>
        <corresp>Correspondence to: Dr J Aguirre-Lamban, Fundacion Jimenez Diaz, Genetics Department, Reyes Catolicos 2, 28.040 Madrid, Spain; <email>jaguirre@fjd.es</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>21</day>
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
			<pub-date pub-type="epub"/>. -->
      <volume>93</volume>
      <issue>5</issue>
      <fpage>614</fpage>
      <lpage>621</lpage>
      <history>
        <date date-type="accepted">
          <day>6</day>
          <month>10</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© Aguirre-Lamban et al 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="openaccess" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background/aims:</title>
          <p>Mutations in <italic>ABCA4</italic> have been associated with autosomal recessive Stargardt disease (STGD), a few cases with autosomal recessive coneârod dystrophy (arCRD) and autosomal recessive retinitis pigmentosa (arRP). The purpose of the study was threefold: to molecularly characterise families with no mutations or partially characterised families; to determine the specificity and sensitivity of the genotyping microarray; and to evaluate the efficiency of different methodologies.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>23 STGD, five arCRD and three arRP Spanish patients who were previously analysed with the ABCR400 microarray were re-evaluated. Results were confirmed by direct sequencing. In patients with either none or only one mutant allele, <italic>ABCA4</italic> was further analysed by denaturing high-performance liquid chromatography (dHPLC) and multiplex ligation-dependent probe amplification (MLPA). Haplotype analysis was also performed.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>In the first analysis performed with the microarray, 27 <italic>ABCA4</italic> variants (27/62; 43.5%) were found. By dHPLC scanning, 12 novel mutations were additionally identified. In addition, two previously described mutations, one false negative (1/62; 1.6%) and one false positive (1.6%), were detected. MLPA analysis did not reveal additional substitutions. The new strategy yielded an increment of 21% compared with the approach used in the first round.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p><italic>ABCA4</italic> should be analysed by optimal combination of high-throughput screening techniques such as microarray, dHPLC and direct sequencing. To the best of our knowledge, this strategy yielded significant mutational spectrum identification in Spanish patients with <italic>ABCA4</italic>-associated phenotypes. Follow-up of patients, presenting an early onset of the disease and severe mutations, seems essential to perform accurate genotypeâphenotype correlations and further characterisation of pathological <italic>ABCA4</italic> alleles.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Stargardt disease (STGD, MIM #248200) is the most common hereditary macular dystrophy, with an estimated prevalence of 1:10Â 000.<xref ref-type="bibr" rid="b1">1</xref> It is characterised by onset in the juvenile to young adult years, decreased central vision, progressive bilateral atrophy of the retinal pigment epithelium (RPE) and the appearance of orange-yellow flecks around the macula and/or mid-periphery of the retina.<xref ref-type="bibr" rid="b2">2</xref></p>
    <p>The locus for recessive STGD was mapped to chromosome 1 (1p21âp13).<xref ref-type="bibr" rid="b3">3</xref> Mutations in <italic>ABCA4</italic> have been described in autosomal recessive STGD (arSTGD),<xref ref-type="bibr" rid="b4">4</xref> autosomal recessive retinitis pigmentosa (arRP),<xref ref-type="bibr" rid="b5">5</xref> autosomal recessive coneârod dystrophy (arCRD)<xref ref-type="bibr" rid="b6">6</xref> and age-related macular degeneration (AMD).<xref ref-type="bibr" rid="b7">7</xref></p>
    <p>Up to now, â¼500 disease-causing mutations have been identified in <italic>ABCA4</italic>. The mutation spectrum ranges from single base substitutions to deletions of several exons, although the majority of reported changes are missense mutations. As has been described, mutations in this gene account for 66â80% of STGD-associated chromosomes.<xref ref-type="bibr" rid="b8">8</xref> <xref ref-type="bibr" rid="b9">9</xref></p>
    <p>Despite all the efforts of many research teams, there is a variable mutation detection rate, and this is often not satisfactory because there are still many undiscovered mutations. Therefore, the combination of different technical approaches, together with knowledge of the genetic background for a given population is important for the determination of novel mutations and for the genetic characterisation of these patients.</p>
    <sec sec-type="methods" id="s2">
      <title>METHODS</title>
      <sec id="s2a">
        <title>Recruitment of subjects</title>
        <p>A subset of Spanish STGD, arCRD and arRP patients previously tested for variants on the ABCR400 genotyping microarray described by Jaakson <italic>et al</italic>,<xref ref-type="bibr" rid="b10">10</xref> in whom none or only one allele could be identified, was selected for further analysis. This molecular study was reviewed and approved by the Ethics Committee of the Hospital (Fundacion Jimenez Diaz) and adhered to the tenets of the Declaration of Helsinki (<ext-link ext-link-type="uri" xlink:href="http://www.wma.org">http://www.wma.org</ext-link>). Informed consent was obtained from all patients after the nature of procedures to be performed was fully explained.</p>
      </sec>
      <sec id="s2b">
        <title>Clinical evaluation</title>
        <p>Diagnoses of STGD, arCRD and arRP were determined according to a recessive mode of inheritance and were based on the following criteria:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diagnosis of STGD was determined according to a bilateral central vision loss with a beaten-bronze appearance and/or the presence of orange-yellow flecks in the retina from the posterior pole to the mid-periphery; typical dark choroid observed by fluorescein angiography; and normal to subnormal electroretinograms (ERGs).</p>
          </list-item>
          <list-item>
            <p>Diagnosis of CRD was based in initial complaints of blurred central vision without a history of night blindness, poor visual acuity, impairment of colour vision, funduscopic evidence of atrophic macular degeneration, peripheral disturbances including pigment clumping and/or pigment epithelial thinning, and greater or earlier loss of cone than rod ERG amplitude.</p>
          </list-item>
          <list-item>
            <p>RP was diagnosed in patients who developed night blindness early in life, peripheral vision loss, pigmentary retinal degeneration and markedly reduced scotopic ERG.</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s3">
      <title>MOLECULAR METHODS</title>
      <sec id="s3a">
        <title>DNA extraction</title>
        <p>Peripheral blood samples were taken, and genomic DNA was extracted using an automated DNA extractor (BioRobot EZ1, Qiagen, Hilden, Germany).</p>
      </sec>
      <sec id="s3b">
        <title>Genotyping microarray</title>
        <p>DNA samples from patients were analysed for variants on the ABCR400 microarray (<ext-link ext-link-type="uri" xlink:href="http://www.asperbio.com">http://www.asperbio.com</ext-link>), as described elsewhere.<xref ref-type="bibr" rid="b10">10</xref> The 50 exons of the <italic>ABCA4</italic> gene, including the intronâexon junctions, were amplified using previously described PCR primers.<xref ref-type="bibr" rid="b11">11</xref></p>
      </sec>
      <sec id="s3c">
        <title>Direct sequencing</title>
        <p>The sequencing reaction was performed with the Big-dye DNA Sequencing Kit (Applied Biosystems, Foster City, California). Sequence products were resolved in an ABIPrism 3130 (Applied Biosystems).</p>
      </sec>
      <sec id="s3d">
        <title>Denaturing high-performance liquid chromatography</title>
        <p>Denaturing high-performance liquid chromatography (dHPLC) sample screening was performed on a WAVE DNA Fragment Analysis System (Transgenomic). Because dHPLC does not usually differentiate the wild-type from the homozygous mutant sample, all unknown samples were analysed both singularly and mixed in a 1:1 proportion with a wild-type sample at the end of each PCR session and before heteroduplex formation.</p>
      </sec>
      <sec id="s3e">
        <title>Multiplex ligation-dependent probe amplification</title>
        <p>Multiplex ligation-dependent probe amplification (MLPA) reagents were obtained from MRC-Holland (SALSA MLPA kit P151-P152 ABCA4, Amsterdam), and the reactions were performed according to the manufacturerâs instructions (MRC-Holland).</p>
      </sec>
      <sec id="s3f">
        <title>Fluorescent-PCR</title>
        <p>In order to assess the size of one duplication found in exon 40 of the <italic>ABCA4</italic> gene, the PCR product was analysed in the ABIPrism 3130 (Applied Biosystems).</p>
      </sec>
      <sec id="s3g">
        <title>Restriction assays</title>
        <p>The presence of one novel missense mutation (p.Ile2047Asn) was analysed in 100 control chromosomes by conventional PCR amplification, restriction enzyme digestion (37Â°C overnight) with <italic>TaqI</italic> and analyses of the restriction fragments in a 3% agarose gel.</p>
      </sec>
      <sec id="s3h">
        <title>Haplotype analysis</title>
        <p>Haplotypes were constructed using three microsatellite markers flanking the <italic>ABCA4</italic> gene (TEL-D1S435-D1S2804-<italic>ABCA4</italic>-D1S236-CEN). Amplicons were electrophoresed using an ABIPrism 3130 (Applied Biosystems). For haplotype reconstruction, a computer program was used (Cyrillic version 2.1; <ext-link ext-link-type="uri" xlink:href="http://www.cyrillicsoftware.com">http://www.cyrillicsoftware.com</ext-link>).</p>
      </sec>
      <sec id="s3i">
        <title>Bioinformatics tool</title>
        <p>In order to establish the nature of the variants located in the introns of the <italic>ABCA4</italic> gene, wild type and mutated sequences were analysed with Prediction Servers of Intron Splice Sites in human (Center for Biological Sequence Analysis of University of Denmark (<ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services">http://www.cbs.dtu.dk/services</ext-link>)).</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>RESULTS</title>
      <sec id="s4a">
        <title>Molecular analysis</title>
        <sec id="s4a1">
          <title>Further analysis of partially characterised families and identification of novel variants</title>
          <p>A total of 31 Spanish patients, who were previously tested for mutations with the ABCR400 microarray, were further analysed with two different techniques: dHPLC and MLPA. In 27 out of 31 patients, only one disease-associated allele was detected using the genotyping microarray, and in the remaining cases, no variant was detected by the chip (four out of 31 patients). Therefore, the mutation detection rate for the microarray was 43.5%. However, a subsequent analysis performed by dHPLC (<xref ref-type="fig" rid="bj1-93-05-0614-f01">fig 1</xref>) led to the identification of 24 sequence variations in the <italic>ABCA4</italic> gene (<xref ref-type="table" rid="bj1-93-05-0614-t01"/><xref ref-type="table" rid="bj1-93-05-0614-t02">tables 1, 2</xref>).</p>
          <fig id="bj1-93-05-0614-f01" position="float">
            <label>Figure 1</label>
            <caption>
              <p>Chromatograms showing differences between the wild-type (down) and mutated profile (up). The wild-type sample shows a single peak, but the mutated sample shows different peaks. In some cases, the difference between chromatograms is very significant (B, C and D); in other cases, it is not so (A). Nevertheless, these samples were confirmed by sequencing for all family members.</p>
            </caption>
            <graphic xlink:href="BJ1-93-05-0614-f01"/>
          </fig>
          <table-wrap id="bj1-93-05-0614-t01" position="float">
            <label>Table 1</label>
            <caption>
              <title>Clinical findings of the Spanish patients with Stargardt disease (STGD), autosomal recessive coneârod dystrophy and autosomal recessive retinitis pigmentosa</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td rowspan="2" align="left" colspan="1">Pedigree</td>
                  <td rowspan="2" align="left" colspan="1">Age (years)</td>
                  <td rowspan="2" align="left" colspan="1">Age (years) of onset</td>
                  <td colspan="2" align="left" rowspan="1">Visual acuity</td>
                  <td rowspan="2" align="left" colspan="1">Diagnosis</td>
                  <td colspan="2" align="left" rowspan="1">Allele 1</td>
                  <td colspan="2" align="left" rowspan="1">Allele 2</td>
                  <td rowspan="2" align="left" colspan="1">Segregation</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">OD</td>
                  <td align="left" rowspan="1" colspan="1">OS</td>
                  <td align="left" rowspan="1" colspan="1">Nucleotide changes (exons)</td>
                  <td align="left" rowspan="1" colspan="1">Amino acid change</td>
                  <td align="left" rowspan="1" colspan="1">Nucleotide changes (exons)</td>
                  <td align="left" rowspan="1" colspan="1">Amino acid change</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-135</td>
                  <td align="left" rowspan="1" colspan="1">42</td>
                  <td align="left" rowspan="1" colspan="1">24</td>
                  <td align="left" rowspan="1" colspan="1">0.4</td>
                  <td align="left" rowspan="1" colspan="1">0.6</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.5882G&gt;A(42)</td>
                  <td align="left" rowspan="1" colspan="1">p.Gly1961Glu</td>
                  <td align="left" rowspan="1" colspan="1">c.1029_1030insT<bold>(8)</bold></td>
                  <td align="left" rowspan="1" colspan="1">p.Asn344fsX</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>NP</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-240</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">13</td>
                  <td align="left" rowspan="1" colspan="1">0.2</td>
                  <td align="left" rowspan="1" colspan="1">0.16</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.5882G&gt;A(42)</td>
                  <td align="left" rowspan="1" colspan="1">p.Gly1961Glu</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.2285C&gt;A</bold>(15)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Ala762Glu</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-225</td>
                  <td align="left" rowspan="1" colspan="1">32</td>
                  <td align="left" rowspan="1" colspan="1">25</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">0.50</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.5882G&gt;A(42)</td>
                  <td align="left" rowspan="1" colspan="1">p.Gly1961Glu</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.6559C&gt;T</bold>(48)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Gln2187X</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-164</td>
                  <td align="left" rowspan="1" colspan="1">21</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td colspan="2" align="left" rowspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3386G&gt;T(23)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1129Leu</td>
                  <td align="left" rowspan="1" colspan="1">c.700C&gt;T<bold>(6)</bold></td>
                  <td align="left" rowspan="1" colspan="1">p.Gln234X</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>Yes</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-162</td>
                  <td align="left" rowspan="1" colspan="1">50</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3386G&gt;T(23)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1129Leu</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-198</td>
                  <td align="left" rowspan="1" colspan="1">27</td>
                  <td align="left" rowspan="1" colspan="1">19</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3386G&gt;T(23)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1129Leu</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-125</td>
                  <td align="left" rowspan="1" colspan="1">31</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">0.3</td>
                  <td align="left" rowspan="1" colspan="1">0.4</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3211insGT(22)</td>
                  <td align="left" rowspan="1" colspan="1">FS</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.KNLFA1876dup</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-158</td>
                  <td align="left" rowspan="1" colspan="1">24</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">0.2</td>
                  <td align="left" rowspan="1" colspan="1">0.2</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3211insGT(22)</td>
                  <td align="left" rowspan="1" colspan="1">FS</td>
                  <td align="left" rowspan="1" colspan="1">c.4537delC<bold>(30)</bold></td>
                  <td align="left" rowspan="1" colspan="1">p.Gln1513fsX1525</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>NP</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-165</td>
                  <td align="left" rowspan="1" colspan="1">40</td>
                  <td align="left" rowspan="1" colspan="1">30</td>
                  <td colspan="2" align="left" rowspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3211insGT(22)</td>
                  <td align="left" rowspan="1" colspan="1">FS</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-167</td>
                  <td align="left" rowspan="1" colspan="1">49</td>
                  <td align="left" rowspan="1" colspan="1">23</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3211insGT(22)</td>
                  <td align="left" rowspan="1" colspan="1">FS</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-146</td>
                  <td align="left" rowspan="1" colspan="1">32</td>
                  <td align="left" rowspan="1" colspan="1">13</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3056C&gt;T(21)</td>
                  <td align="left" rowspan="1" colspan="1">p.Thr1019Met</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.6140T&gt;A</bold>(44)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Ile2047Asn</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-40</td>
                  <td align="left" rowspan="1" colspan="1">46</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3056C&gt;T(21)</td>
                  <td align="left" rowspan="1" colspan="1">p.Thr1019Met</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.3943C&gt;T</bold>(27)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Gln1315X</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-90</td>
                  <td align="left" rowspan="1" colspan="1">26</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td colspan="2" align="left" rowspan="1">Hand moving</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.5929G&gt;A (43)</td>
                  <td align="left" rowspan="1" colspan="1">p.Gly1977Ser</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>IVS21-2A&gt;T</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-181</td>
                  <td align="left" rowspan="1" colspan="1">57</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">0.09</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.3323G&gt;A (22)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1108His</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>IVS38+5G&gt;A</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-197</td>
                  <td align="left" rowspan="1" colspan="1">35</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.4793C&gt;A(34) (false +)</td>
                  <td align="left" rowspan="1" colspan="1">p.Ala1598Asp (false +)</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.5172G&gt;T</bold>(36)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Trp1724Cys</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-183</td>
                  <td align="left" rowspan="1" colspan="1">63</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                  <td align="left" rowspan="1" colspan="1">0.150</td>
                  <td align="left" rowspan="1" colspan="1">0.175</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.6079C&gt;T(44)</td>
                  <td align="left" rowspan="1" colspan="1">p.Leu2027Phe</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.5929G&gt;A</bold>(43) (false â)</td>
                  <td align="left" rowspan="1" colspan="1"><bold>p.Gly1977Ser</bold> (false â)</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-38</td>
                  <td align="left" rowspan="1" colspan="1">35</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">0.01</td>
                  <td align="left" rowspan="1" colspan="1">0.02</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.1804C&gt;T(13)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg602Trp</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.4739delT</bold>(33)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Leu1580fs</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-163</td>
                  <td align="left" rowspan="1" colspan="1">48</td>
                  <td align="left" rowspan="1" colspan="1">32</td>
                  <td align="left" rowspan="1" colspan="1">0.01</td>
                  <td align="left" rowspan="1" colspan="1">0.32</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.4457C&gt;T(30)</td>
                  <td align="left" rowspan="1" colspan="1">p.Pro1486Leu</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-166</td>
                  <td align="left" rowspan="1" colspan="1">42</td>
                  <td align="left" rowspan="1" colspan="1">39</td>
                  <td colspan="2" align="left" rowspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.6320G&gt;A(46)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg2107His</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-222</td>
                  <td align="left" rowspan="1" colspan="1">26</td>
                  <td align="left" rowspan="1" colspan="1">23</td>
                  <td colspan="2" align="left" rowspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.2791G&gt;A(19)</td>
                  <td align="left" rowspan="1" colspan="1">p.Val931Met</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-160</td>
                  <td align="left" rowspan="1" colspan="1">30</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-173</td>
                  <td align="left" rowspan="1" colspan="1">49</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td colspan="2" align="left" rowspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-205</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td colspan="2" align="left" rowspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">STGD</td>
                  <td align="left" rowspan="1" colspan="1">c.4919G&gt;A(35)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1640Gln</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-247</td>
                  <td align="left" rowspan="1" colspan="1">30</td>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">CRD</td>
                  <td align="left" rowspan="1" colspan="1">c.3386G&gt;T(23)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1129Leu</td>
                  <td align="left" rowspan="1" colspan="1"><bold>c.6410G&gt;A</bold>(47)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Cys2137Tyr</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-99</td>
                  <td align="left" rowspan="1" colspan="1">59</td>
                  <td align="left" rowspan="1" colspan="1">46</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">CRD</td>
                  <td align="left" rowspan="1" colspan="1">c.4297G&gt;A(29)</td>
                  <td align="left" rowspan="1" colspan="1">p.Val1433Ile</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-131</td>
                  <td align="left" rowspan="1" colspan="1">27</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">0.9</td>
                  <td align="left" rowspan="1" colspan="1">0.7</td>
                  <td align="left" rowspan="1" colspan="1">CRD</td>
                  <td align="left" rowspan="1" colspan="1">c.2701A&gt;G(18)</td>
                  <td align="left" rowspan="1" colspan="1">p.Thr901Ala</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-100</td>
                  <td align="left" rowspan="1" colspan="1">28</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">0.2</td>
                  <td align="left" rowspan="1" colspan="1">0.16</td>
                  <td align="left" rowspan="1" colspan="1">CRD</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARDM-142</td>
                  <td align="left" rowspan="1" colspan="1">30</td>
                  <td align="left" rowspan="1" colspan="1">25</td>
                  <td align="left" rowspan="1" colspan="1">0.8</td>
                  <td align="left" rowspan="1" colspan="1">0.5</td>
                  <td align="left" rowspan="1" colspan="1">CRD</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RP-773</td>
                  <td align="left" rowspan="1" colspan="1">38</td>
                  <td align="left" rowspan="1" colspan="1">20</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">RP</td>
                  <td align="left" rowspan="1" colspan="1">c.33N86G&gt;T(23)</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg1129Leu</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RP-959</td>
                  <td align="left" rowspan="1" colspan="1">53</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">0.1</td>
                  <td align="left" rowspan="1" colspan="1">RP</td>
                  <td align="left" rowspan="1" colspan="1">c.466A&gt;G(5)</td>
                  <td align="left" rowspan="1" colspan="1">p.Ile156Val</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RP-1058</td>
                  <td align="left" rowspan="1" colspan="1">37</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">0.2</td>
                  <td align="left" rowspan="1" colspan="1">0.6</td>
                  <td align="left" rowspan="1" colspan="1">RP</td>
                  <td align="left" rowspan="1" colspan="1">c.4297G&gt;A(29)</td>
                  <td align="left" rowspan="1" colspan="1">p.Val1433Ile</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">ND</td>
                  <td align="left" rowspan="1" colspan="1">NP</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="nt101">
                <p>Twenty-seven out of 31 subjects were found to be compound heterozygous for mutations in the <italic>ABCA4</italic> gene detected by microarray. These mutations were confirmed by the denaturing high-performance liquid chromatography (dHPLC) technique and sequencing analysis. In patients from families ARDM-135, ARDM-240, ARDM-225, ARDM-164, ARDM-125, ARDM-158, ARDM-146, ARDM-40, ARDM-90, ARDM-181, ARDM-197, ARDM-183, ARDM-38 and ARDM-247, the second mutation was found by dHPLC (in bold).</p>
              </fn>
              <fn id="nt101a">
                <p>FS, frameshift; NA, not available; ND, not detected; NP, not performed; OD, right eye; OS, left eye.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="bj1-93-05-0614-t02" position="float">
            <label>Table 2</label>
            <caption>
              <title>Synonymous and non-synonymous codon variants and intronic variants in the ABCA4 gene</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Exon</td>
                  <td align="left" rowspan="1" colspan="1">Nucleotide change</td>
                  <td align="left" rowspan="1" colspan="1">Sequence change</td>
                  <td align="left" rowspan="1" colspan="1">Reference</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>c.264 A&gt;T</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Gly88Gly</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>IVS2-27G&gt;A</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">IVS3+26 A&gt;G</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="b9">9</xref>
                    <xref ref-type="bibr" rid="b15">15</xref>
                    <xref ref-type="bibr" rid="b18">18</xref>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">IVS6-32 T&gt;C</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="b9">9</xref>
                    <xref ref-type="bibr" rid="b15">15</xref>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>c.1029T&gt;C</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Asn343Asn</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>c.1299A&gt;G</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Glu433Glu</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>c.1654G&gt;A</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Val552Ile</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>IVS13+16G&gt;A</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">19</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>c.2832A&gt;G</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Pro944Pro</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">20</td>
                  <td align="left" rowspan="1" colspan="1">c.2964C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Leu988Leu</td>
                  <td align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="b18">18</xref>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">23</td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>c.3507G&gt;A</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>p.Gln1169Gln</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">IVS28+43G&gt;A</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="b24">24</xref>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">IVS43-16G&gt;A</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="b25">25</xref>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>IVS48+39 T&gt;A</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">This study</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">IVS48-3T&gt;C</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="b15">15</xref>
                    <xref ref-type="bibr" rid="b18">18</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="nt101b">
                <p>Novel changes are shown in bold.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Eight of these changes were interpreted as null mutations: three were nonsense mutations (p.Gln234X, p.Gln1315X âde novoâ and p.Gln2187X); two splice-site mutations (IVS22-2A&gt;T and IVS38+5G&gt;A); three frameshift variants: two caused by the insertion or deletion of one nucleotide (c.1029_1030insT and c.4739delT) and one duplication of five amino acids (p.KNLFA1876dup). We were able to determine that this duplication was of maternal inheritance (<xref ref-type="fig" rid="bj1-93-05-0614-f02">fig 2</xref>). Three missense changes were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in patients but not in the 100 ethnically matched control chromosomes. We identified the heterozygous p.Ile2142Val change in one out of 100 control chromosomes. Interestingly, this variant has not been previously described and was not found in Spanish STGD/CRD patients. Moreover, two previously described mutations [c.4537delC and p.Trp1724Cys], not included in the array by the time of the screening, and one false negative [p.Gly1977Ser] were detected (1/62; 1.6%).</p>
          <fig id="bj1-93-05-0614-f02" position="float">
            <label>Figure 2</label>
            <caption>
              <p>Electropherogram showing the five-amino-acid duplication (p.KNLFA1876dup) in the patient from family ARDM-125. By this design, we could confirm that this gain was of maternal origin.</p>
            </caption>
            <graphic xlink:href="BJ1-93-05-0614-f02"/>
          </fig>
          <p>Despite these putative disease-associated alleles, additional variants interpreted as non-pathogenic were identified. Additionally, one novel change in exon 12 (p.Val552Ile) was found in one STGD patient by means of the dHPLC technique. This variant was detected in two alleles out of 200, suggesting a polymorphism. We also found six variants that did not produce a change at the protein level, five being novel ones and eight intronic variants, three of them previously unreported (<xref ref-type="table" rid="bj1-93-05-0614-t02">table 2</xref>). These three changes located in the introns were analysed with a bioinformatics tool. According to this analysis, these variants are not predicted to affect the splicing process.</p>
          <p>Finally, in 17 of 31 patients in whom the second mutant allele or no disease-associated alleles were found, we assessed dosage for the <italic>ABCA4</italic> locus using the MLPA technique. No deletions or duplications were found for any of the 48 amplified probes in these cases. These results were compared with two control samples.</p>
          <p>Despite the high allelic heterogeneity and the large amount of novel <italic>ABCA4</italic> variants detected in this screening, the p.Arg1129Leu mutation was found to be the most frequent disease-associated allele (5/62; 8%).</p>
          <p>Segregation analyses were performed in all families in which samples from additional family members were available. In 11 STGD families and one CRD family, where an additional pathogenic change was found, correct segregation of the disease alleles was demonstrated (<xref ref-type="fig" rid="bj1-93-05-0614-f03">fig 3</xref>). Haplotype analysis was also performed, and cosegregation was observed (available on request).</p>
          <fig id="bj1-93-05-0614-f03" position="float">
            <label>Figure 3</label>
            <caption>
              <p>Family pedigrees, all diagnosed as having Stargardt disease except for family ARDM-247 whose proband presents a coneârod dystrophy phenotype. The family number is shown above each pedigree. Probands are indicated with an arrow.</p>
            </caption>
            <graphic xlink:href="BJ1-93-05-0614-f03"/>
          </fig>
          <p>The combination of direct sequencing, together with dHPLC and MLPA techniques allowed us to further analyse the <italic>ABCA4</italic> gene in STGD, arCRD and arRP cases, therefore leading to the identification of 21 novel sequence variants. In addition, the specificity, sensitivity and efficiency of different methodologies were evaluated.</p>
        </sec>
        <sec id="s4a2">
          <title>Determination of sensitivity and specificity of the ABCR400 microarray</title>
          <p>We identified 1.6% (1/62) of false positives and 1.6% (1/62) of false negatives for the ABCR400 microarray. In the patient belonging to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct sequencing demonstrated that this mutation was not present (false positive). Interestingly, the p.Trp1724Cys mutation was detected by dHPLC in this family. In contrast, the dHPLC technique led to the detection of the p.Gly1977Ser mutation in the patient from the family ARDM-183, but the chip did not detect it (false negative). Therefore, the values of sensitivity and specificity of the genotyping microarray were 96.3% and 97.1%, respectively.</p>
        </sec>
        <sec id="s4a3">
          <title>Evaluation of the efficiency of different methodologies</title>
          <p>The genotyping microarray identified a total of 27 disease-associated alleles, yielding a mutation detection rate of 43.5%. As we currently confirm these results by sequencing, a false positive [p.Ala1598Asp] was identified. Altogether, the combination of several high-throughput approachesâABCR400 microarray, dHPLC, MLPA and direct sequencing as a confirmation methodâled to the detection of 12 novel mutations and one false negative. Therefore, the detection rate was increased by 21%, mainly due to dHPLC scanning, achieving a mutation detection rate of 64.5% (40/62). Moreover, two previously described pathogenic variants were also detected. In addition, nine novel polymorphisms were identified.</p>
        </sec>
      </sec>
      <sec id="s4b">
        <title>Genotypeâphenotype correlation</title>
        <sec id="s4b1">
          <title>STGD patients presenting one putative null allele</title>
          <p>Importantly, putative null mutationsâincluding frameshifts, nonsense, or splice-site variantsâwere observed more frequently (7/31 patients; 22.6%) in compound heterozygous alleles from patients with age of onset of the disease &lt;10 years, all of them presenting a STGD phenotype (<xref ref-type="table" rid="bj1-93-05-0614-t01">table 1</xref>). A total of 13 putative null disease-associated alleles (13/62; 20.9%) were identified in this study. The majority of patients who presented at least one putative null mutation presented early-onset symptoms, except for two STGD patients belonging to the families ARDM-135 and ARDM-225, whose disease started at the age of 24â25 years. Moreover, both patients presented the p.Gly1961Glu mutation, which is considered an allele of moderate effect.<xref ref-type="bibr" rid="b7">7</xref></p>
        </sec>
        <sec id="s4b2">
          <title>STGD patients presenting two putative null alleles</title>
          <p>Patients from families ARDM-125 and ARDM-158 were carrying two putative null <italic>ABCA4</italic> alleles (<xref ref-type="table" rid="bj1-93-05-0614-t01">table 1</xref>). Both of them harboured the previously reported c.3211insGT mutation. For the second disease-associated allele, the patient from family ARDM-125 showed a duplication of five amino acids (p.KNLFA1876dup), while the patient from family ARDM-158 presented the frameshift c.4537delC mutation. Probands from these families presented a STGD phenotype, presenting symptoms since the age of 9.</p>
        </sec>
        <sec id="s4b3">
          <title>Patients presenting arCRD and arRP phenotypes</title>
          <p>Interestingly, in our patients with arCRD and arRP phenotypes, no putative null mutations were found (<xref ref-type="table" rid="bj1-93-05-0614-t01">table 1</xref>). In three arRP cases, the second disease-associated allele was not identified. In one of them, cosegregation of the mutation within the family was observed.</p>
        </sec>
      </sec>
    </sec>
    <sec id="s5">
      <title>DISCUSSION</title>
      <p>Thirty-one Spanish families were analysed for mutations in <italic>ABCA4</italic>. This gene encodes the <italic>ABCA4</italic> protein, a member of the ATP-binding cassette (ABC) transport super-family. It is involved in the transport of vitamin A derivates across the membrane of the outer segment discs of photoreceptors.<xref ref-type="bibr" rid="b12">12</xref> <xref ref-type="bibr" rid="b13">13</xref></p>
      <p>The frequency of mutated alleles found with the microarray was 43.5% (27/62; 33.8% (21/62) for STGD patients, 4.8% (3/62) for arCRD patients and 4.8% (3/62) for arRP patients). However, the frequency of mutated alleles detected with microarray and dHPLC was 54.8% (34/62) for STGD patients and 6.4% (4/62) for arCRD patients. In contrast, the mutation detection rate for arRP cases was not increased by dHPLC scanning, as no additional disease-associated alleles were found.</p>
      <p>The p.Arg1129Leu mutation was found to be the most frequent missense variant, representing 8% (5/62) of the total pathogenic alleles (<xref ref-type="table" rid="bj1-93-05-0614-t01">table 1</xref>). In previous studies of the Spanish population, the p.Arg1129Leu variant was identified as a major mutant allele which accounted for 24% of the STGD alleles.<xref ref-type="bibr" rid="b14">14</xref> This variant has been postulated to have a moderately severe effect and has predominantly been associated with a STGD phenotype.<xref ref-type="bibr" rid="b14">14</xref> In contrast, the prevalence of this mutation in patients from North America was less than 1%.<xref ref-type="bibr" rid="b15">15</xref> Interestingly, we identified one 30-year-old patient (ARDM-247), double heterozygous for the p.Arg1129Leu and p.Cys2137Tyr alleles, who presented a CRD phenotype. This p.Cys2137Tyr change was located more towards the amino terminus. Moreover, in other study, the results showed that the changes located in this zone appear to result in altered processing of the protein and to be associated with an earlier onset of disease.<xref ref-type="bibr" rid="b16">16</xref> The p.Cys2137Tyr change in combination with the p.Arg1129Leu allele produced a CRD phenotype. Therefore, we speculate that the novel p.Cys2137Tyr variant could be a severe allele which is modifying the patientâs phenotype.</p>
      <p>The second most prevalent missense disease-associated allele was p.Gly1961Glu (3/62; 4.8%), presenting a lower frequency than other European populations.<xref ref-type="bibr" rid="b10">10</xref> This mutation was found in three STGD patients, two of them presenting at least one putative null mutation (c.1030insT and p.Gln2187X), who presented symptoms at the age of 24â25 years. Thus, we could suspect a moderate effect for the p.Gly1961Glu allele, as previously reported.<xref ref-type="bibr" rid="b7">7</xref></p>
      <p>In relation to null alleles, the most frequent mutation was c.3211insGT, identified in four independent STGD families out of 31 (6.4%). In two of these cohorts (ARDM-125 and ARDM-158), the second mutated allele was found by dHPLC (p.KNLFA1876dup and c.4537delC, respectively). In both patients, first symptoms of the disease appeared at the age of 9 years old. Nevertheless, in patients from families ARDM-165 and ARDM-167, in whom the second disease-associated allele was not detected, the age of onset of the disease was at the third decade of life (<xref ref-type="table" rid="bj1-93-05-0614-t01">table 1</xref>). Therefore, we speculate that the secondânot yet detectedâmutation might be of a moderate effect, as the disease started later in life. The c.3211insGT allele has been previously described in other studies.<xref ref-type="bibr" rid="b17">17</xref><sup>â</sup><xref ref-type="bibr" rid="b19">19</xref>. Rozet <italic>et al</italic><xref ref-type="bibr" rid="b17">17</xref> reported two STGD patients who were compound heterozygous for the c.3211insGT allele and another sequence change, whose age of onset was before 12 years old.<xref ref-type="bibr" rid="b17">17</xref> In other population study performed by Briggs <italic>et al</italic>,<xref ref-type="bibr" rid="b18">18</xref> two STGD patients harbouring the heterozygous c.3211insGT allele were described. These probands presented reduced central visual acuity before the age of 30. Interestingly, Paloma <italic>et al</italic><xref ref-type="bibr" rid="b19">19</xref> described one CRD case, compound heterozygous for the c.3211insGT and p.Arg212Cys variants, showing symptoms at the age of 9. Considering these previously reported genotypeâphenotype correlations, together with the genetic and clinical findings described in our Spanish patients, we could hypothesise that the c.3211insGT variant is predominantly associated with STGD, while the second mutated allele might have a modulating effect on the patientâs phenotype.</p>
      <p>Two additional null alleles, associated with STGD, were identified. The patient from family ARDM-125 presented the novel p.KNLFA1876dup, located at the second transmembrane region of the <italic>ABCR</italic> protein, while the patient from family ARDM-158 harboured the frameshift c.4537delC variant that causes a premature stop codon 12 amino acids downstream.</p>
      <p>Nevertheless, as the c.3211inGT, p.KNLFA1876dup and c.4537delC are null alleles, and some patients presented symptoms early in life (9 years), we cannot rule out that they could develop a more severe phenotype (arCRD) in the future. Indeed, a similar situation has been previously reported in one Spanish patient homozygous for the c.2888delG allele,<xref ref-type="bibr" rid="b20">20</xref> whose clinical phenotype changed from STGD (age of onset 10 years) to arCRD (age of diagnosis 26 years), during the course of the study.</p>
      <p>Two novel splice-site alterations were described, IVS21-2A&gt;T (ARDM-90) and IVS38+5G&gt;A (ARDM-181). Both patients presented STGD phenotype, and the age of onset of the disease corresponded to the first and second decade of life, respectively. In these cases, the total inactivation of the splice site is unlikely, although these changes could alter the splicing of corresponding exon, creating cryptic sites, thus producing a longer protein.<xref ref-type="bibr" rid="b21">21</xref></p>
      <p>In two patients diagnosed as having arCRD and arRP phenotypes respectively, we identified the missense p.Val1433Ile mutation, located in the second transmembrane domain. This sequence change has been previously associated with age-related macular degeneration (AMD)<xref ref-type="bibr" rid="b7">7</xref> and has also been reported in one arCRD patient, although it was questioned whether the nature of this amino acid change was pathological or not.<xref ref-type="bibr" rid="b22">22</xref> We investigated this change further in the Spanish control population, and it was not found in 124 ethnically matched chromosomes, thus suggesting a pathogenic effect.</p>
      <p>Family RP-959 was previously analysed by the genotyping microarray, and the p.Ile156Val allele was detected.<xref ref-type="bibr" rid="b20">20</xref> This variant has been associated with the STGD phenotype. In the affected individual, the second mutated allele was not found by dHPLC. Segregation analysis of the mutation within the family did not allow this gene to be excluded. Thus, the presence of RP phenotype and this mutation could be explained because the second mutation would be a severe allele or would be due to fortuitous association. Moreover, in the RP-773 and RP-1058 families, it was not possible to detect the second mutated allele, so the implication of mutations in this gene in the development of RP is still not clear as was previously reported.<xref ref-type="bibr" rid="b20">20</xref></p>
      <p>To establish the nature of the three non-reported changes located in the introns, we used a bioinformatics tool to analyse and compare the wild type and mutated sequences. The results demonstrated that these variants probably did not modify the splicing process.</p>
      <p>By MLPA analysis, no deletions or duplications were found in patients. Indeed, it has been suggested that these alterations contribute to only a small fraction of disease-associated alleles for <italic>ABCA4</italic>.<xref ref-type="bibr" rid="b23">23</xref></p>
      <p>The genotyping microarray is a comprehensive screening tool for genetic variation in patients with <italic>ABCA4</italic>-associated retinal pathology with a high reliability. Despite the relative small number of families, a huge number of <italic>ABCA4</italic> disease-associated alleles were identified, representing an increment of 4% of novel variants described in this gene, as â¼500 sequence changes have been described so far. To the best of our knowledge, this optimal screening strategy represents extensive mutational spectrum identification in Spanish patients with <italic>ABCA4</italic>-associated phenotypes.</p>
      <p>Moreover, these new mutations could be added to the new versions of the ABCR400 microarray, thus increasing the detection and validity of the array. The combination of these three different techniques of screening (microarray, dHPLC and MLPA) allowed us to reach a complete diagnosis of 14 of 31 patients with only one mutant allele identified, because of the detection of the second disease-associated allele with by dHPLC. In addition, it is probable that a great number of mutations might reside in parts of the gene (eg, the promoter region or the introns) that have not yet been identified.</p>
      <p>Given an estimated prevalence of STGD (1:10Â 000), the HardyâWeinberg equilibrium would indicate that the heterozygous state can be expected in about 1/50.<xref ref-type="bibr" rid="b24">24</xref> So many variants, such as p.Val552Ile, could be really a mutation found in normal population. Thus, expression analysis could be an interesting tool with which to discriminate the pathological effect of these changes.</p>
      <p>Screening of increasingly large numbers of patients from distinct populations would help to determine whether this broad spectrum of mutations can be explained by ethnic differences or is an indicator of extensive allelic heterogeneity of <italic>ABCA4</italic> in Stargardt disease and other retinal diseases. Follow-up of patients, especially those presenting an early onset of the disease and harbouring severe <italic>ABCA4</italic> mutations, would help in performing accurate genotypeâphenotype correlations and in further characterisation of pathological alleles.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank all patients and controls for their participation in this study.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1">
        <label>1</label>
        <citation citation-type="book"><person-group person-group-type="author"><name><surname>Blacharski</surname><given-names>PA</given-names></name></person-group> <article-title>Fundus flavimaculatus.</article-title><person-group person-group-type="editor"><name><surname>Newsome</surname><given-names>D A</given-names></name></person-group>, eds. <source>Retinal dystrophies and degenerations</source> <publisher-loc>New York</publisher-loc>: <publisher-name>Raven Press</publisher-name>, <year>1988</year>:<fpage>135</fpage>â<lpage>59</lpage></citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stargardt</surname><given-names>K</given-names></name></person-group> <article-title>Uber familiare, progressive degeneration in der maculagegend des auges.</article-title><source>Graefes Arch Ophthalmol</source><year>1909</year>;<volume>71</volume>:<fpage>534</fpage>â<lpage>50</lpage></citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>J</given-names></name><name><surname>Gerber</surname><given-names>S</given-names></name><name><surname>Larget-Piet</surname><given-names>D</given-names></name><etal/></person-group> <article-title>A gene for Stargardtâs disease (fundus flavimaculatus) maps to the short arm of chromosome 1.</article-title><source>Nat Genet</source><year>1994</year>;<volume>6</volume>:<fpage>214</fpage></citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allikmets</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><etal/></person-group> <article-title>A photoreceptor cell-specific ATP-binding transporter gene (<italic>ABCR</italic>) is mutated in recessive Stargardt macular dystrophy.</article-title><source>Nat Genet</source><year>1997a</year>;<volume>15</volume>:<fpage>236</fpage>â<lpage>46</lpage><pub-id pub-id-type="pmid">9054934</pub-id></citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>MartÃ­nez-Mir</surname><given-names>A</given-names></name><name><surname>Paloma</surname><given-names>E</given-names></name><name><surname>Allikmets</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR.</article-title><source>Nat Genet</source><year>1998</year>;<volume>18</volume>:<fpage>11</fpage>â<lpage>12</lpage><pub-id pub-id-type="pmid">9425888</pub-id></citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cremers</surname><given-names>FP</given-names></name><name><surname>van de Pol</surname><given-names>DJ</given-names></name><name><surname>van Driel</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Autosomal recessive retinitis pigmentosa and coneârod dystrophy caused by splice site mutations in the Stargardtâs disease gene ABCR.</article-title><source>Hum Mol Genet</source><year>1998</year>;<volume>7</volume>:<fpage>355</fpage>â<lpage>62</lpage><pub-id pub-id-type="pmid">9466990</pub-id></citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allikmets</surname><given-names>R</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.</article-title><source>Science</source><comment>1997</comment>;<volume>277</volume>:<fpage>1805</fpage>â<lpage>7</lpage><pub-id pub-id-type="pmid">9295268</pub-id></citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yatsenko</surname><given-names>AN</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Lewis</surname><given-names>RA</given-names></name><etal/></person-group> <article-title>Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4).</article-title><source>Hum Genet</source><year>2001</year>;<volume>108</volume>:<fpage>346</fpage>â<lpage>55</lpage><pub-id pub-id-type="pmid">11379881</pub-id></citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Yatsenko</surname><given-names>AN</given-names></name><etal/></person-group> <article-title>Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration.</article-title><source>Hum Mol Genet</source><year>2001</year>;<volume>10</volume>:<fpage>2671</fpage>â<lpage>8</lpage><pub-id pub-id-type="pmid">11726554</pub-id></citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaakson</surname><given-names>K</given-names></name><name><surname>Zernant</surname><given-names>J</given-names></name><name><surname>KÃ¼lm</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Genotyping microarray (gene chip) for the ABCR (ABCA4) gene.</article-title><source>Hum Mutat</source><year>2003</year>;<volume>22</volume>:<fpage>395</fpage>â<lpage>403</lpage><pub-id pub-id-type="pmid">14517951</pub-id></citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>K</given-names></name><name><surname>StÃ¶hr</surname><given-names>H</given-names></name><etal/></person-group> <article-title>A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration.</article-title><source>Am J Hum Genet</source><year>2000</year>;<volume>67</volume>:<fpage>800</fpage>â<lpage>13</lpage><pub-id pub-id-type="pmid">10958763</pub-id></citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Molday</surname><given-names>RS</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group> <article-title>Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease.</article-title><source>J Biol Chem</source><year>1999</year>;<volume>274</volume>:<fpage>8269</fpage>â<lpage>81</lpage><pub-id pub-id-type="pmid">10075733</pub-id></citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>J</given-names></name><name><surname>Mata</surname><given-names>NL</given-names></name><name><surname>Azarian</surname><given-names>SM</given-names></name><etal/></person-group> <article-title>Insights into the function of Rim protein in photoreceptors and etiology of Stargardtâs disease from the phenotype in abcr knockout mice.</article-title><source>Cell</source><year>1999</year>;<volume>98</volume>:<fpage>13</fpage>â<lpage>23</lpage><pub-id pub-id-type="pmid">10412977</pub-id></citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valverde</surname><given-names>D</given-names></name><name><surname>Riveiro-Alvarez</surname><given-names>R</given-names></name><name><surname>Bernal</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Microarray-based mutation analysis of the ABCA4 gene in Spanish patients with Stargardt disease: evidence of a prevalent mutated allele.</article-title><source>Mol Vis</source><year>2006</year>;<volume>12</volume>:<fpage>902</fpage>â<lpage>28</lpage><pub-id pub-id-type="pmid">16917483</pub-id></citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>AR</given-names></name><name><surname>Heon</surname><given-names>E</given-names></name><name><surname>Lotery</surname><given-names>AJ</given-names></name><etal/></person-group> <article-title>An analysis of allelic variation in the <italic>ABCA4</italic> Gene.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year>;<volume>42</volume>:<fpage>1179</fpage>â<lpage>89</lpage><pub-id pub-id-type="pmid">11328725</pub-id></citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, <italic>ABCR</italic>, in Stargardt Disease.</article-title><source>Am J Hum Genet</source><year>1999</year>;<volume>64</volume>:<fpage>422</fpage>â<lpage>34</lpage><pub-id pub-id-type="pmid">9973280</pub-id></citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rozet</surname><given-names>JM</given-names></name><name><surname>Gerber</surname><given-names>S</given-names></name><name><surname>Souied</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Spectrum of <italic>ABCR</italic> gene mutations in autosomal recessive macular dystrophies.</article-title><source>Eur J Hum Genet</source><year>1998</year>;<volume>6</volume>:<fpage>291</fpage>â<lpage>5</lpage><pub-id pub-id-type="pmid">9781034</pub-id></citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Briggs</surname><given-names>CE</given-names></name><name><surname>Rucinski</surname><given-names>D</given-names></name><name><surname>Rosenfeld</surname><given-names>PJ</given-names></name><etal/></person-group> <article-title>Mutations in <italic>ABCR (ABCA4)</italic> in patients with Stargardt macular degeneration or coneârod degeneration.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year>;<volume>42</volume>:<fpage>2229</fpage>â<lpage>36</lpage><pub-id pub-id-type="pmid">11527935</pub-id></citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paloma</surname><given-names>E</given-names></name><name><surname>Amalia</surname><given-names>Martinez-Mir</given-names></name><name><surname>Vilageliu</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Spectrum of <italic>ABCA4 (ABCR)</italic> gene mutations in Spanish patients with autosomal recessive macular dystrophies.</article-title><source>Hum Mut</source><year>2001</year>;<volume>17</volume>:<fpage>504</fpage>â<lpage>10</lpage><pub-id pub-id-type="pmid">11385708</pub-id></citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valverde</surname><given-names>D</given-names></name><name><surname>Riveiro-Alvarez</surname><given-names>R</given-names></name><name><surname>Aguirre-Lamban</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Spectrum of the ABCA4 gene mutations implicated in severe retinopathies in Spanish patients.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year>;<volume>48</volume>:<fpage>985</fpage>â<lpage>90</lpage><pub-id pub-id-type="pmid">17325136</pub-id></citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allikmets</surname><given-names>R</given-names></name><name><surname>Wasserman</surname><given-names>WW</given-names></name><name><surname>Hutchinson</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Organization of the <italic>ABCR</italic> gene: analysis of promoter and splice junction sequences.</article-title><source>Gene</source><year>1998</year>;<volume>215</volume>:<fpage>111</fpage>â<lpage>22</lpage><pub-id pub-id-type="pmid">9666097</pub-id></citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klevering</surname><given-names>BJ</given-names></name><name><surname>Yzer</surname><given-names>S</given-names></name><name><surname>Rohrschneider</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Microarray-based mutation analysis of the <italic>ABCA4</italic> (<italic>ABCR</italic>) gene in autosomal recessive coneârod dystrophy and retinitis pigmentosa.</article-title><source>Eur J Hum Genet</source><year>2004</year>;<volume>12</volume>:<fpage>1024</fpage>â<lpage>32</lpage><pub-id pub-id-type="pmid">15494742</pub-id></citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riveiro-Alvarez</surname><given-names>R</given-names></name><name><surname>Valverde</surname><given-names>D</given-names></name><name><surname>Lorda-Sanchez</surname><given-names>I</given-names></name><etal/></person-group> <article-title>Partial paternal uniparental disomy (UPD) of chromosome 1 in a patient with Stargardt disease.</article-title><source>Mol Vis</source><year>2007</year>;<volume>13</volume>:<fpage>96</fpage>â<lpage>101</lpage><pub-id pub-id-type="pmid">17277736</pub-id></citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>B</given-names></name><name><surname>Preising</surname><given-names>MN</given-names></name></person-group> <article-title>Age matters-thoughts on a grading system for <italic>ABCA4</italic> mutations.</article-title><source>Graefeâs Arch Clin Exp Ophthalmol</source><year>2005</year>;<volume>243</volume>:<fpage>87</fpage>â<lpage>89</lpage></citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>A</given-names></name><name><surname>Ferrari</surname><given-names>M</given-names></name><name><surname>Soriani</surname><given-names>N</given-names></name></person-group>, <collab><italic>et. at</italic></collab> <article-title>Mutational scanning of the ABCR gene with double-gradient denaturing-gradient gel electrophoresis (DG-DGGE) in Italian Stargardt disease patients.</article-title><source>Hum Genet</source><year>2001</year>;<volume>109</volume>:<fpage>326</fpage>â<lpage>38</lpage><pub-id pub-id-type="pmid">11702214</pub-id></citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papaioannou</surname><given-names>M</given-names></name><name><surname>Ocaka</surname><given-names>L</given-names></name><name><surname>Bessant</surname><given-names>D</given-names></name><etal/></person-group> <article-title>An analysis of <italic>ABCR</italic> mutations in British patients with recessive retinal dystrophies.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2000</year>;<volume>41</volume>:<fpage>16</fpage>â<lpage>19</lpage><pub-id pub-id-type="pmid">10634594</pub-id></citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Competing interests:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Funding:</bold> Thanks to FIS (Sanitary Research Fund) 06/0027, Fundacion Mutua MadrileÃ±a (30171/005), CIBERER (06/07/0036) and EviGenoRet LSHG-CT-2005-512036 for their support. JA-Lâs work is supported by FIS from the Instituto de Salud Carlos III (PI06/0027).</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Ethics approval:</bold> Ethics approval was provided by the Ethics Committee of the Hospital (Fundacion Jimenez Diaz).</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Patient consent:</bold> Obtained.</p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>